جستجوی استاد راهنمای دانشگاهی

Carmelo Bellardita is an Associate Professor in the Department of Neuroscience at the University of Copenhagen's Faculty of Health and Medical Sciences. His research focuses on understanding the neural mechanisms underlying motor control, with particular emphasis on spinal cord function, locomotion circuits, and the consequences of spinal cord injury. He is affiliated with the Kiehn Lab, a prominent neuroscience research group led by Professor Ole Kiehn. Position: Associate Professor Institution: University of Copenhagen Department: Neuroscience Research Focus: Neural circuits for movement, spinal cord physiology, locomotion control Contact: cbellardita@sund.ku.dk ORCID: https://orcid.org/0000-0001-6198-243X Lab Website: https://in.ku.dk/research/kiehn-lab Dr. Bellardita's research program investigates how neural circuits generate and regulate movement, with particular emphasis on spinal cord function. His work spans multiple levels of analysis from cellular and molecular mechanisms to systems-level circuit function and behavioral outcomes. Key research areas include organization of spinal locomotor circuits, sensory processing in motor control, pathophysiological changes following spinal cord injury, and development of therapeutic interventions for movement disorders. His laboratory frequently employs rodent models and techniques including electrophysiology, genetic manipulation, and behavioral analysis. Analysis of Dr. Bellardita's publication record reveals a strong trajectory of impactful research in motor neuroscience. His work demonstrates progression from fundamental studies of spinal cord circuitry to translational research with therapeutic implications. Recent publications show an expansion into neuroimmunology, investigating how immune cells interact with neural circuits to influence motor function. His research appears in top-tier journals including Nature, Nature Communications, and Science Translational Medicine, with his 2018 Nature paper on midbrain circuits controlling locomotion receiving over 300 citations. The broad dissemination of his work through news outlets, social media (including over 200 mentions on X for his most cited paper), and academic platforms demonstrates significant impact within and beyond the neuroscience community. Dr. Bellardita's research has received notable attention across multiple platforms. His work has been featured by numerous news outlets (totaling over 40 mentions across publications), shared extensively on social media including X (over 400 total mentions), Facebook, and Bluesky, and referenced on Wikipedia pages. His most cited paper has reached 590 readers on Mendeley, indicating substantial academic interest. This broad dissemination suggests his research has implications beyond basic neuroscience, potentially influencing clinical approaches to movement disorders and spinal cord injury rehabilitation. Dr. Bellardita maintains active collaborations within the neuroscience community, particularly with Professor Ole Kiehn's research group. His work demonstrates integration of multiple approaches to understand motor control systems, from single-cell transcriptomics to systems-level circuit analysis. The progression of his research from basic circuit mechanisms to translational applications suggests a comprehensive approach to addressing fundamental questions in neuroscience with potential clinical relevance. His recent foray into neuroimmunology represents an innovative direction that bridges traditionally separate fields to address complex questions about motor function.

• Neuroscience
• Motor Control
• Spinal Cord Injury
• +۵ مورد دیگر

Dr. Danni Novakovic serves as a part-time Senior Lecturer Practitioner at Anglia Ruskin University within the Faculty of Science and Engineering, specializing in Computing and Information Science. She joined ARU in 2019 after holding leadership roles including Head of School of Computer Science at the University of Bedfordshire and Head of Computing at the University of West London, with an academic career spanning since 1994. Her educational background comprises: PhD in Mathematics PgCert in Teaching and Learning in Higher Education BSc in Computer Science and Mathematics Research focuses on cryptography-combinatorics intersections for security applications, formal methods, and computational theory. Recent expansions include computer music generation via genetic algorithms and self-configuring security frameworks for mobile devices, reflecting an evolution from theoretical mathematics to applied interdisciplinary security solutions. Publication trends demonstrate foundational work in permutation mathematics (1995-2000), system dynamics for institutional management (2009-2010), and contemporary security applications including EEG biometrics and smartphone anomaly detection (2014-2018), showcasing consistent contributions to cryptographic theory and practical security engineering. Professional recognition includes: Fellow of the British Computer Society Fellow of Higher Education Academy She actively supervises postgraduate research across mathematics, cryptography, and cybersecurity domains while contributing to academic leadership through program committee roles at major conferences including IEEE CIT and WEBIST, alongside extensive curriculum development and quality assurance experience.

• Cryptography
• Information Security
• Formal Methods of Specification
• +۴ مورد دیگر

Antonio Giraldez is the Fergus F. Wallace Professor of Genetics at Yale School of Medicine, where he has led his research laboratory since 2007. He served as Director of Graduate Studies (2012-2016) and Chair of the Genetics Department (2017-2023). His academic appointments span multiple departments and centers including Biochemistry, Quantitative Biology, Biophysics and Structural Biology (BQBS), the Center for RNA Science and Medicine, Yale Cancer Center, Yale Center for Genomic Health, Yale Combined Program in the Biological and Biomedical Sciences (BBS), and the Yale Stem Cell Center. Professor Giraldez's research focuses on understanding the regulatory code that governs gene expression during vertebrate development after fertilization. His lab investigates four interconnected areas: genome activation during the maternal-to-zygotic transition, post-transcriptional regulation of gene expression, modeling of therapeutic mRNA design, and modeling of gene regulatory networks. Using zebrafish as a primary model organism combined with advanced genomic, computational, and imaging approaches, his lab has made significant contributions to understanding how transcription factors activate the embryonic genome and how RNA regulatory elements control mRNA stability and translation. Analysis of Professor Giraldez's recent publications reveals a strong focus on the molecular mechanisms of embryonic development, particularly the maternal-to-zygotic transition where control of development passes from maternal to embryonic factors. His work increasingly integrates high-throughput genomic approaches with computational modeling to decode regulatory elements in RNA that determine stability, translation efficiency, and tissue-specific expression - knowledge directly applicable to therapeutic mRNA design for gene therapy and vaccines. Scientific Awards and Honors: HHMI Faculty Scholar (2016) Blavatnik Award for Young Scientists National Finalist (2016) Vilcek Prize for Creative Promise in Biomedical Science (2014) Pew Scholar in Biomedical Sciences (2008) NYAS Blavatnik Young Investigator Award Finalist (2007) Professor Giraldez has established a productive research program with consistent funding and publication in top-tier journals. His lab maintains active collaborations with researchers across Yale and beyond, as evidenced by his frequent co-authorship with scientists from multiple departments. He has trained numerous students and postdocs who have gone on to independent research careers. The Giraldez Lab maintains a diverse team of researchers working at the intersection of developmental biology and genomics. The lab provides extensive resources including published datasets, computational tools like CRISPRscan, and detailed genomic annotations available through their data repository. Professor Giraldez's research program continues to advance our understanding of fundamental gene regulatory mechanisms with implications for both basic science and therapeutic applications.

• Developmental Biology
• Gene Expression Regulation
• Genomics
• +۹ مورد دیگر

Farren Isaacs is a Professor of Molecular, Cellular and Developmental Biology at Yale School of Medicine with extensive affiliations across Yale University. His primary appointments include the Department of Molecular, Cellular and Developmental Biology, Microbiology, and the Yale Cancer Center. He also participates in the Center for RNA Science and Medicine, Genomics, Genetics and Epigenetics Program, Molecular Cell Biology, Genetics and Development, Yale Combined Program in the Biological and Biomedical Sciences (BBS), and Yale Ventures. Dr. Isaacs received his BS in Bioengineering from the University of Pennsylvania, followed by MS and PhD degrees in Biomedical Engineering and Bioinformatics from Boston University. He completed postdoctoral training at Harvard Medical School before establishing his independent research program at Yale. His research focuses on developing and applying genome engineering technologies to understand and reprogram biological systems. His lab has pioneered approaches like MAGE (Multiplex Automated Genome Engineering) and has made significant contributions to genome recoding, CRISPR-based editing, and synthetic genetic circuit design. Recent work includes engineering genomically recoded organisms with simplified genetic codes and developing precision multiplexed base editing techniques with potential therapeutic applications. Dr. Isaacs' publication record demonstrates sustained innovation in synthetic biology and genome engineering, with high-impact papers spanning from foundational work in the early 2000s to multiple 2025 publications in journals like Nature, Nature Communications, and Science. His research trajectory shows a clear progression from developing basic genome engineering tools to applying these technologies to increasingly complex biological problems. Beckman Young Investigator Award (2012) Rising Young Stars of Science (2008) Dr. Isaacs maintains an active research program with multiple current grants supporting work in genome engineering and synthetic biology. His lab trains graduate students and postdoctoral fellows in cutting-edge genomic technologies while fostering interdisciplinary collaborations across Yale and with external institutions. The lab operates across two locations - at Yale's main Science Hill campus and at the West Campus facility. The Isaacs Lab focuses on developing next-generation genome engineering technologies and applying them to fundamental biological questions and potential therapeutic applications. Current research directions include expanding the genetic code, developing precision editing tools, and creating synthetic biological systems with novel properties and enhanced biocontainment features.

• Synthetic Biology
• Gene Editing
• Genomics
• +۶ مورد دیگر

Professor Ullrich Wüllner serves as Cooperation Unit Leader at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, leading cutting-edge epigenetics research focused on neurodegenerative disorders. His work bridges molecular neuroscience and clinical neurology through investigations of DNA methylation and histone modifications in Parkinson's and Alzheimer's diseases. Dr. Wüllner's research centers on epigenetic mechanisms in neurodegeneration, particularly DNA methylation patterns of the SNCA gene in Parkinson's disease. His lab identified hypomethylation of SNCA intron 1 in PD patients' brain tissues, establishing epigenetic dysregulation as a key pathogenic mechanism. Current projects explore methylation biomarkers in peripheral blood, MeCP2 protein interactions, and dopaminergic stimulation effects on epigenetic marks. Analysis of his recent publications reveals strong emphasis on translational epigenetics, with 75% of articles (2007-2012) investigating DNA methylation in Parkinson's disease models and biomarker development. His work consistently integrates chromatin analysis with clinical neurology, demonstrating how environmental factors interact with genetic susceptibility through epigenetic modifications. As head of the Parkinson Competence Network gene bank, Dr. Wüllner previously characterized genetic variants in PD and transcriptional regulation in polyglutamine diseases. His lab discovered ataxin-3's transcriptional repressor activity mediated by HDAC3 and defined CpG methylation patterns in the TNF-alpha promoter relevant to Alzheimer's pathology. Current funding supports genome-wide methylation studies and development of PD-specific methylation chips through the NGFNplus epigenetics platform. Dr. Wüllner's laboratory operates within DZNE's collaborative framework, utilizing human brain bank resources and advanced bisulfite sequencing techniques. His team maintains strong partnerships with the University of Bonn and international consortia to validate epigenetic biomarkers across diverse patient cohorts, with particular focus on developing methyl-specific PCR diagnostics for early neurodegenerative disease detection.

• Epigenetics
• Neurodegenerative Diseases
• DNA Methylation
• +۵ مورد دیگر

Anne-Marie W. Turner serves as Assistant Professor of Medicine within the Department of Medicine at the University of North Carolina at Chapel Hill School of Medicine, with primary affiliation in the Division of Infectious Diseases and active collaboration with the HIV Cure Center. Her research spans two interconnected domains: HIV latency mechanisms and vascular biology, leveraging epigenetic approaches across both fields. Her research program focuses on epigenetic regulation in disease contexts , initially examining HIV latency through chromatin family proteins using small molecule inhibitors, shRNA knockdown, and CRISPR-targeting. Recent work has expanded significantly into vascular biology, with first-author publications in Nature Genetics (2022) and multiple high-impact cardiovascular papers since 2021. Key methodologies include single-nucleus chromatin accessibility profiling, nanopore-based integration site mapping, and bivalent chemical degraders (PROTACs). Current projects characterize intact provirus integration sites and investigate vascular calcification mechanisms through multi-ancestry genomics. Her publication trajectory reveals a strategic expansion from HIV-focused work to broader applications of epigenetic expertise in cardiovascular disease. Recent articles demonstrate leadership in single-cell meta-analysis of atherosclerosis, coronary artery calcification genetics, and vascular smooth muscle biology, often using innovative techniques like long-read nanopore sequencing. This interdisciplinary approach connects chromatin regulation across infectious and cardiovascular diseases. Dr. Turner maintains active collaborations across UNC departments including Biochemistry and Biophysics, the Center for Integrative Chemical Biology and Drug Discovery, and the HIV Cure Center. Her work receives substantial interdisciplinary recognition through co-authorship in journals spanning virology, cardiology, and genomics.

• HIV Latency
• Vascular Biology
• Epigenetics
• +۵ مورد دیگر

Dr. Piotr Sliz serves as an Associate Professor in Pediatrics and in Biological Chemistry and Molecular Pharmacology at Harvard Medical School, with primary affiliation at Boston Children's Hospital. He leads hospital-wide research computing initiatives and directs the Manton Center for Orphan Disease Research programs. His research spans structural biology, non-coding RNA regulation, and computational genomics, with focus on orphan diseases and rare pediatric conditions. Key methodologies include cryo-EM, bioinformatics, and genomic data integration across international consortia. His work bridges basic structural biology with clinical applications through initiatives like Pediatric Scholar and Children's Rare-Disease Cohorts. Dr. Sliz founded and leads SBGrid, a global structural bioinformatics consortium facilitating software development and computational infrastructure for structural biologists worldwide. His leadership extends to the Longwood-wide CryoEM computing effort and bioinformatics consulting services at Boston Children's Hospital. His publication portfolio demonstrates consistent contributions to structural biology, RNA regulation mechanisms, and pediatric genomics, with recent emphasis on global capacity building (BioStruct-Africa) and precision health partnerships for rare diseases. The work shows strong translational focus from molecular mechanisms to clinical implementation. As leader of hospital-wide research computing since 2016, he has developed critical infrastructure for genomic data access and analysis, directly impacting rare disease diagnosis and outcomes. His SBGrid consortium represents a major international effort in structural biology resource sharing.

• Structural Biology
• Non-coding RNA Regulation
• Genomics
• +۵ مورد دیگر